1 August 2013 in Journal of the Advanced Practitioner in Oncology
1 April 2006 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
1 January 2016 in The Journal of Emergency Medicine
1 October 2017 in Annals of Emergency Medicine
Study Objectives Urinary tract infections (UTI) and sexually transmitted infections (STI) are frequently encountered medical conditions in the emergency department (ED). Antimicrobial therapy prescribed for treatment is empiric due to the delay between obtaining a culture and growth of an organism to direct definitive therapy. A culture review and call-back process is paramount to ensuring appropriate therapy and preventing complications of inadequately treated infections for patients not requiring hospital admission. This project investigates if pharmacist-driven culture follow-up in the ED results in a reduction in time from final culture results to patient contact, when compared to the previous nurse driven process. Methods This is a retrospective pre- and post-intervention analysis in a 40-bed Level 1 trauma center ED that has 72,000 annual visits. All patients with UTI or STI cultures drawn in the ED in whom a change in therapy was indicated after final cultures resulted were included. Pre-intervention, all cultures were reviewed by the third-shift charge nurse and forwarded to the designated advanced practice provider (APP). Pharmacists were consulted at the discretion of the APP. Post-intervention, all cultures were first reviewed by an ED pharmacist who then forwarded results and treatment recommendations to the designated APP. Data was collected via electronic health record from September 2015 to February 2016 and April 2016 to September 2016 for the pre- and post-intervention groups, respectively. The primary outcome measured was time from final culture result to patient contact by the APP. Secondary objectives included: prevalence of treatment failure defined as patient return to the ED within 72 hours (h) for the same medical problem, hospital admission within 30 days of ED visit for related conditions (UTI, pyelonephritis, urosepsis), and percentage of pharmacist recommendations. Statistical analysis was completed with Mann-Whitney U test for continuous data. Results A total of 240 patients were included. Pre-intervention group consisted of 143 patients; 103 UTI patients and 40 STI patients. Post-intervention group consisted of 97 patients; 79 UTI and 18 STI patients. Post-intervention, patients were contacted a median of 19.83 hours earlier than in the pre-intervention group (CI 95%, 17.15-22.5; p<0.001). Post-intervention, median contact time for UTI patients was 15.06 hours earlier (CI 95%, 8.35-19.03; p<0.001) and the median contact time for STI patients was 47.31 hours earlier (CI 95%, 29.1-67.41; p<0.001) than the pre-intervention group. Conclusions Pharmacist-initiated culture review in the ED culture follow-up process reduces time from final culture results to initiation of optimal antibiotic treatment. Routine pharmacist involvement in the culture review process appears to have great value.